{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:48Z","timestamp":1785168588603,"version":"3.55.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/tp.0000000000000557","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T10:47:30Z","timestamp":1422701250000},"page":"1441-1446","source":"Crossref","is-referenced-by-count":26,"title":["Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation"],"prefix":"10.1097","volume":"99","author":[{"given":"Hiang K.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard L.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210129","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predicts prognosis in hepatorenal syndrome: relevance to liver transplantation.","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"R2-26-20210129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs. terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"R3-26-20210129","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.","volume":"43","author":"Skagen","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R4-26-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic shunt in non-transplant cirrhotic with hepa-torenal syndrome: a phase II study.","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"R5-26-20210129","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R6-26-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome.","volume":"9","author":"Wong","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-26-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome.","volume":"28","author":"Arroyo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R8-26-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0016-5085(87)90327-1","article-title":"Effects of renal impairment on liver transplantation.","volume":"93","author":"Rimola","year":"1987","journal-title":"Gastroenterology"},{"key":"R9-26-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"R10-26-20210129","first-page":"2651","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us Am J Transplant.","volume":"6","author":"Gonwa","year":"2006","journal-title":""},{"key":"R11-26-20210129","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-26-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients.","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"R13-26-20210129","first-page":"498","article-title":"Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.","volume":"20","author":"Iwatsuki","year":"1988","journal-title":"Transplant Proc"},{"key":"R14-26-20210129","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/TP.0b013e31816c4e6b","article-title":"Decreased survival in liver transplant patients requiring chronic dialysis: a Canadian experience.","volume":"85","author":"Al Riyami","year":"2008","journal-title":"Transplantation"},{"key":"R15-26-20210129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome.","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"R16-26-20210129","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"key":"R17-26-20210129","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/lt.23401","article-title":"Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.","volume":"18","author":"Chok","year":"2012","journal-title":"Liver Transpl"},{"key":"R18-26-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcomes. A case control study.","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"key":"R19-26-20210129","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transpl"},{"key":"R20-26-20210129","first-page":"1310","article-title":"The diagnosis, treatment and prevention of hepatorenal syndrome.","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"R21-26-20210129","first-page":"S1","article-title":"KDOQIClinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R22-26-20210129","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/lt.21598","article-title":"The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to donor age.","volume":"14","author":"Selzner","year":"2008","journal-title":"Liver Transpl"},{"key":"R23-26-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading of liver allograft rejection: an international consensus document.","volume":"25","author":"Demetris","year":"1997","journal-title":"Hepatology"},{"key":"R24-26-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation.","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"R25-26-20210129","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ki.2008.319","article-title":"The aging kidney.","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"R26-26-20210129","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1016\/S0168-8278(14)61104-1","article-title":"Differences in creatinine between genders could disadvantage infected cirrhotic women: the NACSELD experience. Abstract.","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"R27-26-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis.","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"R28-26-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolatesirolimus maintenance in liver transplantation: the randomized Sparethe Nephron trial.","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transpl"},{"key":"R29-26-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus and renal function in liver transplantation: the ReSpECT study.","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"key":"R30-26-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard dose tacrolimus in liver transplantation: a randomized study.","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transplant"},{"key":"R31-26-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1021763221337","article-title":"Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.","volume":"48","author":"Cassinello","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R32-26-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:17:53Z","timestamp":1620976673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201507000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000557","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}